SAMN31203372
External Id
Orebro University Hospital
INSDC center name
2022-10-07T00:00:00Z
INSDC first public
2022-10-21T11:45:42.628Z
INSDC last update
SRS15349085
INSDC secondary accession
live
INSDC status
JPN
ISO_country_code
Pathogen.cl
NCBI submission model
Pathogen.cl.1.0
NCBI submission package
SRS15349085
SRA accession
H035
alternate_ID
GCA_025758415.1
assembly_ID
National Institute of Infectious Diseases
collected_by
2000
collection_date
2000
collection_year
Zoliflodacin, a novel antimicrobial drug in phase 3 randomized clinical trial for the treatment of gonorrhea have shown promise against a range of different Neisseria gonorrhoeae strains. Herein, we present the complete reference genome sequence of the first zoliflodacin resistant strain (H035) from Japan.
description
GyrB_D429V
genotype
Neisseria
genus
Japan
geo_loc_name
Homo sapiens
host
33
host_age
Gonorrhea
host_disease
recovery
host_disease_outcome
symptomatic
host_disease_stage
healthy
host_health_state
male
host_sex
urethra
isolation_source
urinary tract
isolation_source_category
36.20 N 138.25 E
lat_lon
Neisseria gonorrhoeae
http://purl.obolibrary.org/obo/NCBITaxon_485
organism
H035
strain
Pathogen: clinical or host-associated sample from Neisseria gonorrhoeae
title